Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...

Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY) ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today ...

Toronto-Dominion Bank faces challenges including U.S. AML settlements, restructuring efforts, and suspended medium-term ...

Syndax Pharmaceuticals (Nasdaq: SNDX) will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th at 10:30 a.m. PT/1:30 p.m. ET. Ahead of the presentation, Syndax ...

David Sallman, MD, Moffitt Cancer Center, discussed the trial's impact and the future role of MRD monitoring in treatment strategies for TP53-mutant MDS and AML.

This might be at least partly due to insufficient expression and presentation of LAAs by AML-DCs. Moreover, a part of AML-DC might exert tolerogenic effects on the immune system. Further ...

ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the "Company”, "Zefiro”, or "ZEFI”), an environmental services company specializing in methane abatement operations, today ...

Background: This study aims to identify the hub genes and immune-related pathways in acute myeloid leukemia (AML) to provide new theories for immunotherapy. Methods: We use bioinformatics methods to ...

A solicitor has been fined £27,500 for failing to conduct ’adequate client due diligence’ more than seven years ago while handling a property transaction for international firm Kennedys Law ...